Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0Y4EM
|
|||
Former ID |
DIB008243
|
|||
Drug Name |
Thrombomodulin
|
|||
Synonyms |
THRODULIN Inj; MB-015; MR-33; Thrombomodulin, Mochida/JCR
Click to Show/Hide
|
|||
Indication | Disseminated intravascular coagulation [ICD-11: 3B20; ICD-10: D65; ICD-9: 286.6] | Discontinued in Phase 3 | [1] | |
Company |
Mochida Pharmaceutical Co Ltd
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Thrombomodulin (THBD) | Target Info | Modulator | [2] |
KEGG Pathway | Complement and coagulation cascades | |||
Panther Pathway | Blood coagulation | |||
Pathway Interaction Database | Validated transcriptional targets of AP1 family members Fra1 and Fra2 | |||
Reactome | Common Pathway of Fibrin Clot Formation | |||
Cell surface interactions at the vascular wall | ||||
WikiPathways | Complement and Coagulation Cascades | |||
Nuclear Receptors Meta-Pathway | ||||
Vitamin D Receptor Pathway | ||||
Formation of Fibrin Clot (Clotting Cascade) | ||||
Cell surface interactions at the vascular wall |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800002139) | |||
REF 2 | Thrombomodulin. Nihon Yakurigaku Zasshi. 2000 Nov;116(5):283-9. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.